Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · IEX Real-Time Price · USD
4.350
-0.260 (-5.64%)
At close: Jul 2, 2024, 4:00 PM
4.270
-0.080 (-1.84%)
After-hours: Jul 2, 2024, 7:24 PM EDT

Applied Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019
Market Capitalization
49725937235495467
Market Cap Growth
1745.05%608.33%-84.43%-52.60%5.89%-
Enterprise Value
3512097155400431
PE Ratio
--2.16-0.44-2.22-5.27-10.27
PS Ratio
-1509.5025.89----
PB Ratio
7.39-15.098.993.756.0414.34
P/FCF Ratio
-10.73-4.69-0.47-2.59-6.33-12.87
P/OCF Ratio
-10.73-4.69-0.47-2.59-6.33-12.87
EV/Sales Ratio
-1203.1220.94----
EV/EBITDA Ratio
-2.97-1.75-0.08-1.48-4.30-9.49
EV/EBIT Ratio
-2.96-1.75-0.08-1.47-4.28-9.48
EV/FCF Ratio
-8.55-3.79-0.09-1.71-5.11-11.86
Debt / Equity Ratio
0.01-0.030.220.020.020.06
Debt / EBITDA Ratio
0.000.00-0.01-0.01-0.02-0.04
Debt / FCF Ratio
-0.01-0.01-0.01-0.01-0.02-0.06
Quick Ratio
1.750.700.913.054.562.76
Current Ratio
1.800.761.123.344.833.27
Asset Turnover
-0.010.230000
Interest Coverage
-----167.09-488.39
Return on Equity (ROE)
-2226.80%1309.00%-405.10%-106.40%-79.80%-241.30%
Return on Assets (ROA)
-262.50%-275.80%-138.60%-84.20%-68.90%-121.90%
Return on Capital (ROIC)
-110.55%386.92%-1675.08%-165.36%-112.89%-131.56%
Earnings Yield
-38.94%-46.29%-225.90%-45.00%-18.98%-9.74%
FCF Yield
-13.50%-21.33%-213.81%-38.67%-15.80%-7.77%
Buyback Yield / Dilution
-122.36%-122.72%-47.77%-16.53%-71.19%-134.01%
Total Shareholder Return
-122.36%-122.72%-47.77%-16.53%-71.19%-134.01%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).